Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -12.18% is 50% above its 5-year average of -24.36%, around the middle of its 5-year range (-60.52%–19.97%).
109.62% below its 12-month average of -5.81%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -11.87%.
NET PROFIT MARGIN
-12.18%
NET PROFIT MARGIN AVG TTM
-5.81%
NET PROFIT MARGIN AVG 3Y
-23.72%
NET PROFIT MARGIN AVG 5Y
-24.36%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-109.62%
CURRENT VS 3Y AVG
+48.64%
CURRENT VS 5Y AVG
+50.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-4584.62%
vs the sector median at left
10x Genomics, Inc.
Market Cap
$10.20B
Net Profit Margin
-12.18%
TTM Avg
-5.81%
3Y Avg
-23.72%
5Y Avg
-24.36%
Market Cap
$10.20B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$10.14B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$10.12B
Net Profit Margin
-598.56%
TTM Avg
-1557.47%
3Y Avg
-67611.49%
5Y Avg
-57374.18%
Market Cap
$10.30B
Net Profit Margin
17.03%
TTM Avg
11.20%
3Y Avg
12.20%
5Y Avg
12.89%
Market Cap
$10.03B
Net Profit Margin
6.90%
TTM Avg
6.89%
3Y Avg
6.71%
5Y Avg
6.89%
Market Cap
$10.39B
Net Profit Margin
-31.66%
TTM Avg
-43.66%
3Y Avg
-69.45%
5Y Avg
-91.35%
Market Cap
$9.93B
Net Profit Margin
8.59%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
Market Cap
$9.89B
Net Profit Margin
5.29%
TTM Avg
1.30%
3Y Avg
7.86%
5Y Avg
11.15%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | $10.20B | -12.18% | -5.81% | -23.72% | -24.36% |
| Molina Healthcare, Inc. (MOH)vs › | $10.20B | -0.02% | 1.97% | 2.41% | 2.58% |
| Align Technology, Inc. (ALGN)vs › | $10.14B | 9.99% | 10.36% | 10.48% | 22.21% |
| ImmunityBio, Inc. (IBRX)vs › | $10.12B | -598.56% | -1557.47% | -67611.49% | -57374.18% |
| Globus Medical, Inc. (GMED)vs › | $10.30B | 17.03% | 11.20% | 12.20% | 12.89% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 6.90% | 6.89% | 6.71% | 6.89% |
| Twist Bioscience Corporation (TWST)vs › | $10.39B | -31.66% | -43.66% | -69.45% | -91.35% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 8.59% | -21.22% | -48.94% | 16.61% |
| Repligen Corporation (RGEN)vs › | $9.89B | 5.29% | 1.30% | 7.86% | 11.15% |
| Universal Health Services, Inc. (UHS)vs › | $10.70B | 8.42% | 7.89% | 6.46% | 6.98% |
Operating Margin
-14.3%
Net Profit Margin
-12.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -11.87% |
| 2026-03-31 | -8.93% |
| 2025-12-31 | -9.79% |
| 2025-09-30 | -18.44% |
| 2025-06-30 | 19.97% |
| 2025-03-31 | -22.18% |
| 2024-12-31 | -29.71% |
| 2024-09-30 | -23.58% |
| 2024-06-30 | -24.75% |
| 2024-03-31 | -42.52% |
| 2023-12-31 | -26.61% |
| 2023-09-30 | -60.52% |
| 2023-06-30 | -42.51% |
| 2023-03-31 | -37.79% |
| 2022-12-31 | -11.02% |
| 2022-09-30 | -31.98% |
| 2022-06-30 | -56.24% |
| 2022-03-31 | -37.04% |
| 2021-12-31 | -12.85% |
| 2021-09-30 | -13.70% |
| 2021-06-30 | -9.54% |
| 2021-03-31 | -10.92% |
| 2020-12-31 | -370.33% |
| 2020-09-30 | -91.69% |
| 2020-06-30 | -93.62% |
| 2020-03-31 | -29.40% |
| 2019-12-31 | -9.48% |
| 2019-09-30 | -15.69% |
| 2019-06-30 | -19.49% |
| 2019-03-31 | -6.79% |
| 2018-12-31 | -149.39% |
| 2018-09-30 | -41.92% |
| 2018-06-30 | -18.66% |
| 2018-03-31 | -36.54% |
